Augmentation Review Stays Open as One in Twenty Now Lives Enhanced

LAGOS — Roughly one person in twenty now carries some neural or somatic augmentation, and the regulators charged with governing the newest neural-interface lines spent this week doing what they have done all year: not deciding. The safety review of Somaform Augmetics' interface line remains open and contested, with no clearance issued and none imminent. "The review is not stalled; it is unfinished, which is a different thing," said a regulator quoted by Dr. Naomi Eze at the review's Lagos hearing, where clinicians and augmentation-rights advocates gave testimony that pointed in opposite directions. Julian Morrow, who founded Somaform and advocates for the technology, urged the panel toward a decision. "Five percent is not a fringe. It is a constituency," he said, arguing the caution itself carries a cost. Clinicians on the other bench asked for more longitudinal data. The panel took both submissions and adjourned without a finding — the year's pattern, intact.